NDC product
Bacteriostatic Sodium Chloride
NDC 0404-9953 · Henry Schein, Inc.
Key facts
| Product NDC | 0404-9953 |
|---|---|
| Proprietary name | Bacteriostatic Sodium Chloride |
| Nonproprietary name | Sodium Chloride |
| Substances | SODIUM CHLORIDE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| Labeler | Henry Schein, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA018800 |
| Pharmacologic classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| Marketing start | Jan 12, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: